# DESCRIPTION

## BACKGROUND

- define triple-negative breast cancer
- limitations of current treatments

## BRIEF SUMMARY

- introduce combination therapy

## DETAILED DESCRIPTION

- introduce pharmaceutical compositions and methods
- describe synergistic effect of Eribulin and CYC065
- evaluate effectiveness of Eribulin and CYC065 in inhibiting tumor cell proliferation
- describe pharmaceutical compositions for administration to mammals
- define pharmaceutically acceptable salts and carriers
- describe therapeutically and prophylactically effective amounts
- outline modes of administration and dosage forms
- describe stabilizers and excipients
- provide examples of dosage forms and excipients
- describe preparation of pharmaceutical compositions and dosage forms
- outline methods of treatment and administration
- provide applications of the invention

### Examples

- provide non-limiting examples

